Concepts (98)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Immunoglobulins | 5 | 2024 | 39 | 1.260 |
Why?
|
| Mesenchymal Stem Cells | 4 | 2024 | 72 | 0.940 |
Why?
|
| Myocardial Infarction | 3 | 2025 | 247 | 0.830 |
Why?
|
| Cardiomyopathies | 1 | 2023 | 65 | 0.740 |
Why?
|
| Diastole | 1 | 2019 | 47 | 0.600 |
Why?
|
| Regeneration | 1 | 2019 | 32 | 0.600 |
Why?
|
| Signal Transduction | 3 | 2025 | 2157 | 0.460 |
Why?
|
| Fibroblasts | 6 | 2023 | 281 | 0.460 |
Why?
|
| Receptor, Platelet-Derived Growth Factor alpha | 2 | 2022 | 21 | 0.370 |
Why?
|
| Fibrosis | 4 | 2024 | 169 | 0.320 |
Why?
|
| Mice, Knockout | 5 | 2025 | 1035 | 0.300 |
Why?
|
| Myocardium | 3 | 2025 | 263 | 0.250 |
Why?
|
| Mice | 10 | 2025 | 6644 | 0.250 |
Why?
|
| Adipose Tissue, White | 1 | 2024 | 18 | 0.220 |
Why?
|
| Collagen | 2 | 2022 | 181 | 0.190 |
Why?
|
| Idiopathic Pulmonary Fibrosis | 1 | 2021 | 15 | 0.180 |
Why?
|
| Mice, Inbred C57BL | 3 | 2025 | 1869 | 0.180 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2023 | 187 | 0.170 |
Why?
|
| Bone Morphogenetic Proteins | 1 | 2020 | 28 | 0.170 |
Why?
|
| Animals | 10 | 2025 | 16992 | 0.160 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2020 | 100 | 0.160 |
Why?
|
| Matrix Metalloproteinase 7 | 1 | 2019 | 6 | 0.150 |
Why?
|
| Islets of Langerhans | 1 | 2019 | 16 | 0.150 |
Why?
|
| Calcium Channels, L-Type | 1 | 2019 | 20 | 0.150 |
Why?
|
| Proteomics | 1 | 2022 | 378 | 0.150 |
Why?
|
| Exocytosis | 1 | 2019 | 49 | 0.150 |
Why?
|
| Cricetulus | 1 | 2019 | 82 | 0.150 |
Why?
|
| CHO Cells | 1 | 2019 | 123 | 0.150 |
Why?
|
| Cricetinae | 1 | 2019 | 241 | 0.150 |
Why?
|
| Carcinoma, Pancreatic Ductal | 1 | 2019 | 67 | 0.140 |
Why?
|
| Liver Neoplasms | 1 | 2020 | 224 | 0.140 |
Why?
|
| Insulin | 1 | 2019 | 258 | 0.130 |
Why?
|
| Cell Differentiation | 4 | 2024 | 638 | 0.130 |
Why?
|
| Pancreatic Neoplasms | 1 | 2019 | 218 | 0.120 |
Why?
|
| DNA-Binding Proteins | 1 | 2019 | 561 | 0.120 |
Why?
|
| Protein Binding | 1 | 2019 | 1082 | 0.120 |
Why?
|
| Cells, Cultured | 1 | 2019 | 1621 | 0.110 |
Why?
|
| Colorectal Neoplasms | 1 | 2020 | 512 | 0.110 |
Why?
|
| Humans | 7 | 2024 | 43102 | 0.100 |
Why?
|
| Insulin Resistance | 2 | 2024 | 201 | 0.080 |
Why?
|
| Blood Glucose | 2 | 2024 | 389 | 0.080 |
Why?
|
| Stromal Cells | 2 | 2019 | 55 | 0.070 |
Why?
|
| Disease Progression | 2 | 2020 | 667 | 0.070 |
Why?
|
| Prognosis | 2 | 2020 | 861 | 0.070 |
Why?
|
| Pyruvate Kinase | 1 | 2025 | 18 | 0.060 |
Why?
|
| Thyroid Hormones | 1 | 2025 | 35 | 0.060 |
Why?
|
| Mice, Obese | 1 | 2024 | 42 | 0.050 |
Why?
|
| Cell Size | 1 | 2024 | 46 | 0.050 |
Why?
|
| Adipocytes | 1 | 2024 | 60 | 0.050 |
Why?
|
| Interleukin-6 | 1 | 2025 | 165 | 0.050 |
Why?
|
| Cell Lineage | 1 | 2024 | 104 | 0.050 |
Why?
|
| Cell Line, Tumor | 2 | 2020 | 2676 | 0.050 |
Why?
|
| Phenylephrine | 1 | 2022 | 34 | 0.050 |
Why?
|
| Male | 4 | 2025 | 23409 | 0.050 |
Why?
|
| Bleomycin | 1 | 2021 | 20 | 0.050 |
Why?
|
| Angiotensin II | 1 | 2022 | 102 | 0.050 |
Why?
|
| Extracellular Matrix | 1 | 2022 | 131 | 0.040 |
Why?
|
| Proteome | 1 | 2022 | 152 | 0.040 |
Why?
|
| Macrophages | 1 | 2025 | 529 | 0.040 |
Why?
|
| Hepatocytes | 1 | 2020 | 80 | 0.040 |
Why?
|
| Myocytes, Cardiac | 1 | 2022 | 183 | 0.040 |
Why?
|
| Genes, Synthetic | 1 | 2019 | 5 | 0.040 |
Why?
|
| Calcium | 1 | 2022 | 491 | 0.040 |
Why?
|
| Mice, Inbred NOD | 1 | 2019 | 51 | 0.040 |
Why?
|
| Neoplasm Transplantation | 1 | 2019 | 129 | 0.040 |
Why?
|
| Glucose Tolerance Test | 1 | 2019 | 75 | 0.040 |
Why?
|
| Amyotrophic Lateral Sclerosis | 1 | 2019 | 58 | 0.040 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2020 | 347 | 0.040 |
Why?
|
| Inflammation | 1 | 2025 | 758 | 0.040 |
Why?
|
| Motor Skills | 1 | 2019 | 46 | 0.040 |
Why?
|
| Patch-Clamp Techniques | 1 | 2019 | 228 | 0.040 |
Why?
|
| Oxidative Stress | 1 | 2025 | 1003 | 0.040 |
Why?
|
| Lung | 1 | 2021 | 492 | 0.040 |
Why?
|
| Disease Models, Animal | 1 | 2024 | 1596 | 0.040 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2019 | 296 | 0.040 |
Why?
|
| Aged | 2 | 2021 | 8214 | 0.040 |
Why?
|
| Up-Regulation | 1 | 2020 | 536 | 0.030 |
Why?
|
| Cell Nucleus | 1 | 2019 | 383 | 0.030 |
Why?
|
| Vitamin D | 1 | 2019 | 196 | 0.030 |
Why?
|
| Mice, Transgenic | 1 | 2019 | 665 | 0.030 |
Why?
|
| Pregnancy | 1 | 2022 | 1772 | 0.030 |
Why?
|
| Female | 3 | 2022 | 24698 | 0.030 |
Why?
|
| Bone Development | 1 | 2016 | 28 | 0.030 |
Why?
|
| 3T3-L1 Cells | 1 | 2016 | 18 | 0.030 |
Why?
|
| Pericytes | 1 | 2016 | 21 | 0.030 |
Why?
|
| Case-Control Studies | 1 | 2019 | 1285 | 0.030 |
Why?
|
| Osteoblasts | 1 | 2016 | 44 | 0.030 |
Why?
|
| Cell Count | 1 | 2016 | 145 | 0.030 |
Why?
|
| Bone and Bones | 1 | 2016 | 114 | 0.030 |
Why?
|
| Membrane Glycoproteins | 1 | 2016 | 224 | 0.030 |
Why?
|
| Adipose Tissue | 1 | 2016 | 182 | 0.030 |
Why?
|
| Aged, 80 and over | 1 | 2020 | 2853 | 0.030 |
Why?
|
| Immunohistochemistry | 1 | 2016 | 934 | 0.030 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2019 | 968 | 0.030 |
Why?
|
| Gene Expression | 1 | 2016 | 701 | 0.020 |
Why?
|
| Neurons | 1 | 2019 | 1263 | 0.020 |
Why?
|
| Middle Aged | 1 | 2020 | 12222 | 0.010 |
Why?
|
| Adult | 1 | 2020 | 13872 | 0.010 |
Why?
|